Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $30 From $60, Maintains Outperform Rating
Oppenheimer Raises Eloxx Pharmaceuticals Price Target to $60 From $55, Maintains Outperform Rating
Oppenheimer Adjusts Eloxx Pharmaceuticals' Price Target to $55 From $50, Keeps Outperform Rating
Oppenheimer Reiterates Outperform on Eloxx Pharmaceuticals, Maintains $50 Price Target
Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $50 From $3, Maintains Outperform Rating
No Data